or Try an Advanced Search...

    Technical Analysis for ELV - Elevance Health, Inc.

    Grade Last Price % Change Price Change
    F 397.48 0.83% 3.28
    ELV closed up 0.83 percent on Wednesday, November 20, 2024, on 1.38 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ELV trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 0.00%
    New 52 Week Low Weakness 0.00%
    Outside Day Range Expansion 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 0.83%
    Lower Bollinger Band Walk Weakness 0.83%
    New 52 Week Low Weakness 0.83%
    Below Lower BB Weakness 0.83%
    Gapped Down Weakness 0.83%
    Older End-of-Day Signals for ELV ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Lower Bollinger Band about 22 hours ago
    Fell Below Previous Day's Low about 22 hours ago
    Up 1% about 22 hours ago
    New 52 Week Low about 22 hours ago
    60 Minute Opening Range Breakdown 2 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ELV Chart by TradingView
    Basic chart:

    Profile

    Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately 43 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner.
    Classification
    Sector: Healthcare
    Industry: Health Care Plans
    Keywords: S&P 500

    Is ELV a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 20 These 19 stocks are poised for tax reform turbocharge - Jefferies
    Nov 19 Trump Picks Dr. Oz As Centers For Medicare And Medicaid Services Administrator
    Nov 19 Elevance Health price target lowered to $483 from $495 at Wells Fargo
    Nov 17 Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
    Nov 16 Insiders At Elevance Health Sold US$12m In Stock, Alluding To Potential Weakness
    Nov 15 Elevance Health, Inc. (ELV) UBS Global Healthcare Conference (Transcript)
    Nov 12 Elevance Health Declines 20% in 3 Months: Time to Sell the Stock?
    Nov 9 Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
    Nov 5 Elevance Health Announces Appearance at UBS Global Healthcare Conference
    Nov 4 Elevance Health Appoints Nathan Rich Vice President, Investor Relations
    See more ELV news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 560.4297
    52 Week Low 391.02
    Average Volume 1,736,593
    200-Day Moving Average 508.44
    50-Day Moving Average 466.48
    20-Day Moving Average 413.43
    10-Day Moving Average 410.13
    Average True Range 11.06
    RSI (14) 29.58
    ADX 45.44
    +DI 10.93
    -DI 36.73
    Chandelier Exit (Long, 3 ATRs) 400.66
    Chandelier Exit (Short, 3 ATRs) 424.21
    Upper Bollinger Bands 433.51
    Lower Bollinger Band 393.34
    Percent B (%b) 0.1
    BandWidth 9.71
    MACD Line -17.56
    MACD Signal Line -18.64
    MACD Histogram 1.0828
    Fundamentals Value
    Market Cap 93.39 Billion
    Num Shares 235 Million
    EPS 25.20
    Price-to-Earnings (P/E) Ratio 15.77
    Price-to-Sales 0.69
    Price-to-Book 3.03
    PEG Ratio 0.85
    Dividend 5.92
    Dividend Yield 1.49%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 411.00
    Resistance 3 (R3) 410.34 405.19 408.74
    Resistance 2 (R2) 405.19 401.74 405.51 407.99
    Resistance 1 (R1) 401.33 399.62 403.26 401.99 407.24
    Pivot Point 396.18 396.18 397.14 396.50 396.18
    Support 1 (S1) 392.32 392.73 394.25 392.98 387.72
    Support 2 (S2) 387.17 390.61 387.49 386.97
    Support 3 (S3) 383.31 387.17 386.22
    Support 4 (S4) 383.97